We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$203B
AUM Growth
+$19.6B
Cap. Flow
+$8.95B
Cap. Flow %
4.4%
Top 10 Hldgs %
24.49%
Holding
9,765
New
1,572
Increased
4,159
Reduced
2,819
Closed
1,012

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$702M
2
AMAT icon
Applied Materials
AMAT
+$507M
3
KDP icon
Keurig Dr Pepper
KDP
+$387M
4
KEY icon
KeyCorp
KEY
+$383M
5
V icon
Visa
V
+$349M

Sector Composition

Rank Sector Weight
1 Financials 6.16%
2 Technology 4.5%
3 Industrials 4.26%
4 Consumer Discretionary 4.07%
5 Healthcare 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFE
9251
DELISTED
Safeguard Scientifics, Inc.
SFE
-19,643
Closed -$241K
RPT
9252
PUT
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-10,100
Closed -$125K
FRTX
9253
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
-57
Closed -$26.8K
FRTX
9254
PUT
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
-34
Closed -$16K
CYTO
9255
DELISTED
Altamira Therapeutics Ltd
CYTO
-3
Closed -$45K
EMAN
9256
DELISTED
eMagin Corporation
EMAN
-14,875
Closed -$22K
CGRN
9257
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
-2,941
Closed -$34K
TRTN
9258
CALL
DELISTED
Triton International Limited
TRTN
-25,300
Closed -$774K
INFI
9259
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-21,511
Closed -$43.5K
ACGN
9260
CALL
DELISTED
Aceragen Inc
ACGN
-77
Closed -$19K
ACGN
9261
DELISTED
Aceragen Inc
ACGN
-777
Closed -$194K
KDNY
9262
PUT
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-2,200
Closed -$102K
UNVR
9263
PUT
DELISTED
Univar Solutions Inc.
UNVR
-7,800
Closed -$216K
VRAY
9264
PUT
DELISTED
ViewRay, Inc.
VRAY
-19,000
Closed -$122K
NYMX
9265
CALL
DELISTED
Nymox Pharmaceutical Corp
NYMX
-17,700
Closed -$75K
RNDM
9266
DELISTED
First Trust Developed International Equity Select ETF
RNDM
-6,897
Closed -$353K
DBD
9267
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
-40,100
Closed -$618K
BLCM
9268
CALL
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-1,340
Closed -$88K
BIOC
9269
DELISTED
Biocept, Inc.
BIOC
-8
Closed -$21K
TA
9270
PUT
DELISTED
TravelCenters of America LLC
TA
-2,000
Closed -$36K
FRC
9271
DELISTED
First Republic Bank
FRC
-7,985
Closed -$771K
OIG
9272
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
-363
Closed -$38K
USEQ
9273
DELISTED
Invesco Russell 1000 Enhanced Equal Weight ETF
USEQ
-7,821
Closed -$212K
IVH
9274
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
-11,261
Closed -$160K
CAJ
9275
PUT
DELISTED
Canon, Inc.
CAJ
-5,500
Closed -$200K

Similar funds

Ken Griffin's Q2 2018 Portfolio in Review

As of Q2 2018, Ken Griffin held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ken Griffin deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,159 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.

  • Ken Griffin's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
  • Ken Griffin added most to Citigroup in Q2 2018, an estimated $702M increase.
  • Ken Griffin's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
  • Ken Griffin fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
  • Ken Griffin's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
  • Ken Griffin opened 1,572 new positions and closed 1,012 in Q2 2018.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $203B.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.